Eczema Series

Atopic Eczema Itch and Its Management

Eczema Series

Atopic Eczema Itch and Its Management

Eczema Series

Atopic Eczema Itch and Its Management

Eczema Series

Atopic Eczema Itch and Its Management

Eczema Series

Atopic Eczema Itch and Its Management
Atopic Eczema Itch and Its Management

Eczema Series

Atopic Eczema Itch and Its Management

  • 0.75 credits

  • 50 a la carte

  • ANCC, AMA

Supported by independent educational grants from Incyte, Pfizer and Sanofi Genzyme and Regeneron Pharmaceuticals
Atopic Eczema Itch and Its Management

Eczema Series

Atopic Eczema Itch and Its Management

  • 0.75 credits

  • 50 a la carte

  • ANCC, AMA

Supported by independent educational grants from Incyte, Pfizer and Sanofi Genzyme and Regeneron Pharmaceuticals

About this course

General

Skill level: All levels
Estimated time to complete activity: 45 min
Release date: March 19, 2018
Expiration date: December 11, 2020

Languages

English

Accreditations

American Nurses Credentialing Center(ANCC), American Medical Association(AMA)

Description


This activity is part of a 16-course series designed to equip licensed practitioners from medical, nursing, and related disciplines with a multidisciplinary approach to managing patients with atopic dermatitis (AD), also known as eczema. 

14. Atopic Eczema Itch and Its Management

To many experts, itch defines eczema, as eczema is the “itch that rashes.” To most patients, itch represents the most devastating, daily struggle with the condition. Although many conventional eczema treatments address the inflammation and barrier pathologies, itch is often neglected or poorly responsive to treatment. Itch is also the first symptom to occur and the last symptom to dissipate in eczema. Therefore, practitioners need specific tools to address itch in patients with eczema. The specific mechanisms that lead to itch and management strategies are presented. 

Educational Objectives

After completing this activity, participants will be able to:

  • Define mechanisms of itch in AD
  • Appraise available therapies to reduce itch in AD
  • Discuss coping mechanisms for managing itch in AD
Name Reported Financial Disclosure
Reviewer: Hadar Lev-Tov, MD LearnHealth founder and shareholder
Planner: Venita Sivamani LearnHealth founder and shareholder

Faculty/Speaker Disclosure(s)

All planning committee members, reviewers, planners, and faculty identified conflicts of interest pertaining to this activity were resolved prior to the activity.

COI Resolution: Ensure a balanced discussion of research and practice. Avoid trade names, company names, and logos. Medical advice will not be provided.

Name Reported Financial Disclosure
Gil Yosipovitch, MD

Grants/Research Support: Sun Pharma, Pfizer, Sanofi

Consultant: Sanofi, TREVI, Menlo, Novartis, Sienna, Galderma

Type of Activity

Online internet enduring

Physician Credit

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Education Resources (MER) and LearnHealth. MER is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Medical Education Resources designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit

Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This CE activity provides 0.75 contact hours of continuing nursing education.

Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299 for 0.75 contact hours.

Contact Information

This activity is jointly provided by Medical Education Resources and LearnHealth Inc.

For questions regarding accreditation, please contact MER at 800-421-3756. For all other questions, please contact info@learnskin.com.

This activity is subject to MER's Privacy Policy and LearnSkin's Terms of Use.